Dr. Dronamraju Delivers Opening Address in Shanghai, China

Dr. Krishna Dronamraju, President of the Foundation for Genetic Research in Houston, delivered the opening address at the Third Conference on Biomarkers and Clinical Applications in Shanghai, China. The conference was organized by the Shanghai Biotechnological Institute from 16 to 18 October. In a review of wide ranging list of Biomarkers and their Medical Applications, Dr. Dronamraju covered several important diseases such as many kinds of Cancer including chronic myeloid leukemia, melanoma, prostate cancer, colorectal cancer, breast cancer, as well as multiple sclerosis, Down’s syndrome and many others. Biomarkers are genetic or physiological markers which can provide early indications of a disease, leading to the development of early treatment methods to prevent the development of a full blown disease. Biomarkers of many kinds are being discovered rapidly in recent years because of discoveries in molecular biology and medical genetics. Early detection and treatment are extremely important for the prevention of many types of cancer and other diseases. Biomarkers of many kinds include “Screening Biomarkers”, “Predisposition Biomarkers”, and “Prediction Biomarkers”, and many others.

Dr. Krishna Dronamraju is President of the Foundation for Genetic Research in Houston, and is a Visiting Professor of the University of Paris, France. He is the author of 20 books and over 200 research papers in Biotechnology. He was a member of the U.S. Presidential delegation to India in 2000, and has been actively promoting U.S.-India cooperation in Science and Technology.